文献速递静脉血栓栓塞慢性静脉疾病

慢性静脉性胸廓出口综合征手术治疗长期结果:单中心经验

Long Term Results of Surgical Treatment of Chronic Venous Thoracic Outlet Syndrome: A Single Centre Experience.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2026-10-16

末次随访(12个月)时一期通畅率56%、一期辅助通畅率86%、二期通畅率93%,术后DASH评分显著改善,半数患者需再次PTA。

要点

  • 结构化治疗方案可获良好长期功能结果,术后DASH评分显著下降。
  • 半数患者需再次PTA,但为预期内操作,减少了二次干预需求。
  • 术后并发症率16%,多为血肿,住院时间中位数1天。

核心结论

  • 慢性静脉性胸廓出口综合征可通过结构化手术方案有效治疗,长期功能结果良好。

研究设计与样本

  • 治疗包括经腋窝胸廓出口减压、静脉松解和锁骨下静脉再通,必要时计划再次PTA。

主要发现

  • 术后静脉造影显示15例(21%)持续静脉阻塞并计划再次PTA;随时间推移20例(29%)出现再狭窄,共完成35例(50%)再次PTA。
  • 末次随访(12个月)时一期通畅率56%、一期辅助通畅率86%、二期通畅率93%。
  • 术后DASH评分中位数从术前32.9(15.8–48.3)降至8.0(2.3–27.8),p < .001;平均随访45.7±27.5个月,无患者报告Derkash评分差。

关键数值与推荐

  • 术后DASH评分中位数从术前32.9(15.8–48.3)显著降至8.0(2.3–27.8),p < .001。
  • 末次随访(12个月)一期通畅率56%、一期辅助通畅率86%、二期通畅率93%。

临床怎么用

  • 对慢性静脉性胸廓出口综合征可采用经腋窝减压、静脉松解和锁骨下静脉再通的结构化方案。
  • 预期半数患者需再次PTA,术后应监测再狭窄并及时处理。
  • 该方案可减少二次干预需求和长期抗凝使用。

局限性

  • 原文未报告对照组的比较结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This retrospective cohort study with cross-sectional analysis aimed to evaluate the surgical and long term functional outcomes of a structured treatment algorithm for patients with chronic venous thoracic outlet syndrome (cVTOS). METHODS: Patients with cVTOS and treated at this tertiary centre between 2016 and 2024 were included. Treatment consisted of transaxillary thoracic outlet decompression (TOD), venolysis, and subclavian vein (SCV) recanalisation. In case of persistent venous obstruction during the primary procedure, anticipated repeat percutaneous transluminal angioplasty (PTA) was planned. Anticoagulation (rivaroxaban) was prescribed until 48 hours before surgery, resumed the day after surgery for six weeks, or until 48 hours before re-PTA. The primary endpoint included SCV patency and secondary outcomes included functional outcomes (DASH and Derkash scores). RESULTS: Seventy patients were included (mean age 35 years; 56% women). Median time to presentation was 40 (20.0 - 104.0) months after initial upper extremity deep vein thrombosis (UEDVT). Eleven patients (16%) had an operative complication (haematoma n = 6, pneumothorax n = 1, UEDVT n = 1, transient Horner syndrome n = 1, phrenic nerve injury n = 1, and SCV rupture n = 1). Median length of hospital stay was 1.0 day. Venography post-TOD/PTA showed persistent venous obstruction in 15 patients (21%) for which re-PTA was planned. Over time, 20 patients (29%) developed re-stenosis. A total of 35 (50%) re-PTAs were performed. Primary patency was 56%, primary assisted patency was 86%, and secondary patency was 93% at last follow up (12 months). Median post-operative DASH score decreased significantly (pre-op: 32.9 (15.8 - 48.3) vs. post-op 8.0 (2.3 - 27.8); p < .001) with a mean follow up of 45.7 ± 27.5 months. Zero patients reported a poor Derkash score. CONCLUSION: Chronic VTOS can be effectively treated with good long term functional outcomes. Re-PTAs were necessary in half of the cases (anticipated). This treatment algorithm diminished the need of secondary interventions in 50% of the cases, as well as the need for long term anticoagulation usage.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Teijink SBJ, Yadav R, Dujardin YY, et al. Long Term Results of Surgical Treatment of Chronic Venous Thoracic Outlet Syndrome: A Single Centre Experience. Eur J Vasc Endovasc Surg. 2026. PMID: 42887642. doi:10.1016/j.ejvs.2026.10.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。